Skye Bioscience Inc. is developing The Conscience Collective to support leaders building successful and sustainable organisations while understanding the wider role of health and healthcare innovation in society.
Public source
Publisher name
Public post
We spend a great deal of time talking about the cost of healthcare. I sometimes wonder whether we spend enough time talking about the value of health. I have believed fo…
Company
Skye Bioscience Inc.
Unlocking new therapeutic pathways for metabolic health
- Industry
- Biotechnology Research
- Location
- San Diego, US
- Company size
- 11–50 employees
About Skye Bioscience Inc.
Skye Bioscience (Nasdaq: SKYE) is focused on unlocking new therapeutic pathways for metabolic health through the development of next-generation molecules that modulate G-protein coupled receptors. Skye's strategy leverages biologic targets with substantial human proof of mechanism for the development of first-in-class therapeutics with clinical and commercial differentiation. Skye plans to start a Phase 2 clinical trial in obesity in Q3 2024 for nimacimab, a negative allosteric modulating antibody that peripherally inhibits CB1, comparing monotherapy and combination arms of nimacimab and a GLP-1R agonist (Wegovy®).
See moreDiscover more
Similar signals
Similar public activity from other companies.
Strategy & Corporate Development
Attune Biotech
Attune Biotech is entering an important phase of growth after achieving multiple regulatory and clinical milestones.
Strategy & Corporate Development
American Biotech Innovation Alliance (ABIA)
American Biotech Innovation Alliance (ABIA) is working to advance a national biotech strategy through Vision 2030.
Strategy & Corporate Development
Evotec
Evotec's CEO highlighted the Environmental Commitment Statement, which emphasizes embedding environmental responsibility into the company's business to support scientific innovation and reduce environmental footprint.
Strategy & Corporate Development
Lindus
Lindus Therapeutics is in-licensing external assets and developing them through to value inflection points.
Strategy & Corporate Development
Flagship Pioneering